| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product Name | Pneumocandin B0 |
| CAS NO. | 135575-42-7 |
| MF | C50H80N8O17 |
| MW | 1065.21000 |
| PSA | 411.28000 |
| LogP | -1.05910 |
| Density | 1.41g/cm3 |
|---|---|
| Boiling Point | 1442.9ºC at 760mmHg |
| Flash Point | 826.5ºC |
| Refractive Index | 1.629 |
| Vapor Pressure | 0mmHg at 25°C |
| Appearance | White Powder |
| Certificate | ISO, SGS, GMP, HACCP |
| Assay Method | HPLC |
| Extraction Type | Solvent Extraction |
| Sample | Available |
| MOQ | 5g |
| Shelf life | 2 Years |
| Storage | Store in cool & dry place not freeze Keep away from strong light and heat |
Neumocontin B0, an antifungal lipopeptide, is an effective antifungal agent that inhibits the production of β-(1,3) -D-glucan, a basic component of the cell wall of sensitive fungi.It acts by inhibiting the synthesis of β- (1,3) -D-chemicalbook glucan, a fungal cell wall component (IC50=70 and 67ng/ mL for inhibiting glucan synthase and A1 in Candida albicans) and can be used to synthesize carpofungin acanthate acetate.
Application:
Neomocontin B0 can be used as scientific reagents, widely used in molecular biology, pharmacology and other scientific research.
| Other Hot-Selling Similar Products | ||||
| Capecitabine | Everolimus | Afatinib | Vandetanib | Gefitinib |
| Temozolomid | Rapamycin | Axitinib | Sorafenib tosylate | Cediranib |
| Cabozantinib | Selumetinib | Crizotinib | Sunitinib malate | Erlotinib |
| Crizotinib | Lapatinib | Debrafenib | Cabazitaxel | Ponatinib |
){kind=link}